Photo

Photo detail

Biotech Buy: Celgene has long relationship with Soon-Shiong.

Stories this photo appears in:

ImmunityBio Wins FDA Approval for Clinical Testing of Cancer-Fighting Drug

Shares of ImmunityBio, Inc. shot up after the company received FDA authorization to launch clinical studies of a cancer-fighting drug.

Tease photo

Celgene is Investor Behind NantCell $30M

Biotech giant has history of investing in Soon-Shiong cancer treatment companies

Celegene revealed as NantCell’s $30M investor.

Tease photo